Skip Navigation
Skip to contents

JPTM : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Articles and issues > Author index
Search
Kwhanmien Kim 2 Articles
Membranous Insulin-like Growth Factor-1 Receptor (IGF1R) Expression Is Predictive of Poor Prognosis in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma
Eunhyang Park, Soo Young Park, Hyojin Kim, Ping-Li Sun, Yan Jin, Suk Ki Cho, Kwhanmien Kim, Choon-Taek Lee, Jin-Haeng Chung
J Pathol Transl Med. 2015;49(5):382-388.   Published online August 4, 2015
DOI: https://doi.org/10.4132/jptm.2015.07.10
  • 7,198 View
  • 71 Download
  • 14 Citations
AbstractAbstract PDF
Background
Insulin-like growth factor-1 receptor (IGF1R) is a membrane receptor-type tyrosine kinase that has attracted considerable attention as a potential therapeutic target, although its clinical significance in non-small cell lung cancer (NSCLC) is controversial. This study aimed to clarify the clinical significance of IGF1R expression in human NSCLC. Methods: IGF1R protein expression was evaluated using immunohistochemistry in 372 patients with NSCLC who underwent curative surgical resection (146 squamous cell carcinomas [SqCCs] and 226 adenocarcinomas [ADCs]). We then analyzed correlations between expression of IGF1R and clinicopathological and molecular features and prognostic significance. Results: Membranous and cytoplasmic IGF1R expression were significantly higher in SqCCs than in ADCs. In patients with SqCC, membranous IGF1R expression was associated with absence of vascular, lymphatic, and perineural invasion; lower stage; and better progression-free survival (PFS) (hazard ratio [HR], 0.586; p = .040). In patients with ADC, IGF1R expression did not have a significant prognostic value; however, in the subgroup of epidermal growth factor receptor (EGFR)-mutant ADC, membranous IGF1R expression was associated with lymphatic and perineural invasion, solid predominant histology, and higher cancer stage and was significantly associated with worse PFS (HR, 2.582; p = .009). Conclusions: Lung ADC and SqCC showed distinct IGF1R expression profiles that demonstrated prognostic significance. High membranous IGF1R expression was predictive of poor PFS in EGFR-mutant lung ADC, while it was predictive of better PFS in SqCC. These findings will help improve study design for subsequent investigations and select patients for future anti-IGF1R therapy.

Citations

Citations to this article as recorded by  
  • NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells
    Lívia Bassani Lins de Miranda, Keli Lima, Juan Luiz Coelho-Silva, Fabiola Traina, Susumu S. Kobayashi, João Agostinho Machado-Neto
    Scientific Reports.2022;[Epub]     CrossRef
  • IRS2 Amplification as a Predictive Biomarker in Response to Ceritinib in Small Cell Lung Cancer
    Mi-Sook Lee, Kyungsoo Jung, Ji-Young Song, Min-Jung Sung, Sung-Bin Ahn, Boram Lee, Doo-Yi Oh, Yoon-La Choi
    Molecular Therapy - Oncolytics.2020; 16: 188.     CrossRef
  • Understanding Lineage Plasticity as a Path to Targeted Therapy Failure in EGFR-Mutant Non-small Cell Lung Cancer
    Tatiana Shaurova, Letian Zhang, David W. Goodrich, Pamela A. Hershberger
    Frontiers in Genetics.2020;[Epub]     CrossRef
  • Investigating Trk Protein Expression between Oropharyngeal and Non-oropharyngeal Squamous Cell Carcinoma: Clinical Implications and Possible Roles of Human Papillomavirus Infection
    Yoon Ah Cho, Ji Myung Chung, Hyunmi Ryu, Eun Kyung Kim, Byoung Chul Cho, Sun Och Yoon
    Cancer Research and Treatment.2019; 51(3): 1052.     CrossRef
  • NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma
    Eun Kyung Kim, Yoon Ah Cho, Mi-kyoung Seo, Hyunmi Ryu, Byoung Chul Cho, Yoon Woo Koh, Sun Och Yoon
    Scientific Reports.2019;[Epub]     CrossRef
  • Advances in studies of tyrosine kinase inhibitors and their acquired resistance
    Qinlian Jiao, Lei Bi, Yidan Ren, Shuliang Song, Qin Wang, Yun-shan Wang
    Molecular Cancer.2018;[Epub]     CrossRef
  • The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a
    Bo Chen, Qinhua Li, Yongping Zhou, Xujing Wang, Qiqi Zhang, Yongkun Wang, Huiren Zhuang, Xiaohua Jiang, Wujun Xiong
    Cell Cycle.2018; 17(16): 1949.     CrossRef
  • Characterization of head and neck squamous cell carcinoma arising in young patients: Particular focus on molecular alteration and tumor immunity
    Hyang Joo Ryu, Eun Kyung Kim, Byoung Chul Cho, Sun Och Yoon
    Head & Neck.2018;[Epub]     CrossRef
  • Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer
    Yu-Hua Xu, Jian-Ren Tu, Tian-Tian Zhao, Shi-Guang Xie, Sheng-Bo Tang
    International Journal of Oncology.2018;[Epub]     CrossRef
  • IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights
    Heming Li, Izhar Singh Batth, Xiujuan Qu, Ling Xu, Na Song, Ruoyu Wang, Yunpeng Liu
    Molecular Cancer.2017;[Epub]     CrossRef
  • Insulin-like growth factor 1 receptor expression in advanced non-small-cell lung cancer and its impact on overall survival
    Mojca Humar, Izidor Kern, Gregor Vlacic, Vedran Hadzic, Tanja Cufer
    Radiology and Oncology.2017; 51(2): 195.     CrossRef
  • IGF1R depletion facilitates MET-amplification as mechanism of acquired resistance to erlotinib in HCC827 NSCLC cells
    Dianna Hussmann, Anne Tranberg Madsen, Kristine Raaby Jakobsen, Yonglun Luo, Boe Sandahl Sorensen, Anders Lade Nielsen
    Oncotarget.2017; 8(20): 33300.     CrossRef
  • Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas
    Eun Kyung Kim, Sun Och Yoon, Soo Hee Kim, Woo Ick Yang, Yoon Ah Cho, Soo Jeong Kim
    Journal of Pathology and Translational Medicine.2016; 50(2): 104.     CrossRef
  • The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation
    Tu-Chen Liu, Ming-Ju Hsieh, Ming-Che Liu, Whei-Ling Chiang, Thomas Tsao, Shun-Fa Yang
    International Journal of Molecular Sciences.2016; 17(5): 763.     CrossRef
Metaplastic Thymoma: Report of 4 Cases
Guhyun Kang, Nara Yoon, Joungho Han, Young Eun Kim, Tae Sung Kim, Kwhanmien Kim
Korean J Pathol. 2012;46(1):92-95.   Published online February 23, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.1.92
  • 7,179 View
  • 49 Download
  • 9 Citations
AbstractAbstract PDF

Metaplastic thymoma (MT), accepted in the World Health Organization 2004 scheme, is a circumscribed tumor of the thymus exhibiting biphasic morphology. We herein describe the clinicopathologic features of four MTs and the differential diagnoses of this unusual tumor. There were three women and one man with mean age of 49.5 years. The patients were found to have mediastinal masses, and underwent surgical excision. One exhibited symptoms of myasthenia gravis, and the serum titer for anti-acetylcholine receptor antibody was positive. Grossly, the tumors were encapsulated, and showed vaguely multinodular, solid, tan-white to yellow cut surfaces. Histologically, they comprised epithelial islands intertwining with bundles of delicate spindle cells. The patients remained well after surgical excision at 5-55 months. Because of the distinctive histological appearance and benign clinical course, MT should be distinguished from other more aggressive mediastinal neoplasms displaying biphasic feature.

Citations

Citations to this article as recorded by  
  • Epigenetics of Thymic Epithelial Tumors
    Vanessa Nicolì, Fabio Coppedè
    Cancers.2023; 15(2): 360.     CrossRef
  • Expanding the Clinicopathologic Spectrum of YAP1::MAML2–Rearranged Thymic Neoplasm
    Eric Eunshik Kim, Ye Yoon Suh, Sang Won Lee, Jeong Mo Bae, Kyoungbun Lee, Sungyoung Lee, Hongseok Yun, Kyeong Cheon Jung, Jiwon Koh
    Modern Pathology.2023; 36(2): 100048.     CrossRef
  • Malignant Transformation of Metaplastic Thymoma into High-Grade Sarcomatoid Carcinoma: A Case Report
    Zheng Hua Piao, Jin Ping Chen, Hai Ren Chen, Xin Cheng Zhou
    International Journal of Surgical Pathology.2022; 30(5): 564.     CrossRef
  • YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma
    Jikai Zhao, Ruiying Zhao, Chan Xiang, Jinchen Shao, Lianying Guo, Yuchen Han
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions
    Marina Vivero, Phani Davineni, Valentina Nardi, John K.C. Chan, Lynette M. Sholl
    Modern Pathology.2020; 33(4): 560.     CrossRef
  • Metaplastic thymoma: Report of two cases
    Yoshikazu Shinohara, Mariko Tanaka, Kentaro Kitano, Kazuhiro Nagayama, Masaaki Sato, Jun Nakajima
    The Journal of the Japanese Association for Chest Surgery.2020; 34(7): 733.     CrossRef
  • Type AB thymoma is not a mixed tumor of type A and type B thymomas, but a distinct type of thymoma
    Yukari Miki, Kana Hamada, Tadashi Yoshino, Katsuya Miyatani, Kiyoshi Takahashi
    Virchows Archiv.2014; 464(6): 725.     CrossRef
  • Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or Neck
    Jae Myoung Noh, Sang Yun Ha, Yong Chan Ahn, Dongryul Oh, Seung Won Seol, Young Lyun Oh, Joungho Han
    Cancer Research and Treatment.2014; 47(3): 436.     CrossRef
  • A Case of Metaplastic Thymoma
    Eiji MIYAHARA, Tomoko ITAGAKI, Masaki KUWAHARA, Akira KAMEDA, Yoshihiro MIYATA, Kazuhiro SENTANI, Wataru YASUI
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2014; 75(2): 360.     CrossRef

JPTM : Journal of Pathology and Translational Medicine